Michael David Morse
Architects at Tryon Hl Dr, Raleigh, NC
License number
North Carolina 8545
Category
Architecture
Address
Address
910 Tryon Hill Dr SUITE 108, Raleigh, NC 27603
Personal information
See more information about Michael David Morse at radaris.comName
Address
Phone
452 Dickens Dr, Raleigh, NC 27610
4824 Sandberry Ln, Raleigh, NC 27613
4944 Winding Ln, Indian Trail, NC 28079
528 W Peeler St, Salisbury, NC 28146
3630 Craig Ave, Charlotte, NC 28211
Organization information
See more information about Michael David Morse at bizstanding.comM2 Architecture Pllc
2310 Weymouth Ct, Raleigh, NC 27612
Industry:
Architectural Services
Registration:
Mar 1, 2005
Phone:
(919) 889-2305 (Phone)
Member, Managing Member:
Michael Morse (Member, Managing Member)
Categories:
Architects
Professional information
See more information about Michael David Morse at trustoria.com
Inhibition Of Breast Carcinoma Stem Cell Growth And Metastasis
Inhibition Of Breast Carcinoma Stem Cell Growth And Metastasis
US Patent:
2007029, Dec 27, 2007
Filed:
Mar 16, 2007
Appl. No.:
11/724884
Inventors:
Soldano Ferrone - Buffalo NY, US
Xinhui Wang - Williamsville NY, US
Tim Clay - Cary NC, US
Kim Lyerly - Chapel Hill NC, US
Michael Morse - Raleigh NC, US
Gay Devi - Morrisville NC, US
Takuya Osada - Chapel Hill NC, US
Xinhui Wang - Williamsville NY, US
Tim Clay - Cary NC, US
Kim Lyerly - Chapel Hill NC, US
Michael Morse - Raleigh NC, US
Gay Devi - Morrisville NC, US
Takuya Osada - Chapel Hill NC, US
International Classification:
A61K 39/395, A61K 49/00, A61P 35/00, G01N 33/574
US Classification:
424009200, 424130100, 424156100, 435007100
Abstract:
Disclosed is a method for inhibiting the growth of breast carcinoma stem cells. that express High Molecular Weight -Melanoma Associated Antigen (HMW-MAA). The method comprises administering to an individual a composition comprising an antibody reactive with HMW-MAA or a fragment of such an antibody in an amount effective to inhibit the growth of the breast carcinoma cells. Also provided are methods for inhibiting metastasis of breast carcinomas and methods for identifying HMW-MAA+ breast cancer stem cells.
Treatment Of Wnt/Frizzled-Related Diseases
Treatment Of Wnt/Frizzled-Related Diseases
US Patent:
2013000, Jan 3, 2013
Filed:
Sep 21, 2010
Appl. No.:
13/497364
Inventors:
Wei Chen - Chapel Hill NC, US
Minyong Chen - Durham NC, US
H. Kim Lyerly - Chapel Hill NC, US
Lawrence S. Barak - Durham NC, US
Robert Mook - Chapel Hill NC, US
Takuya Osada - Chapel Hill NC, US
Michael A. Morse - Raleigh NC, US
Minyong Chen - Durham NC, US
H. Kim Lyerly - Chapel Hill NC, US
Lawrence S. Barak - Durham NC, US
Robert Mook - Chapel Hill NC, US
Takuya Osada - Chapel Hill NC, US
Michael A. Morse - Raleigh NC, US
International Classification:
A61K 31/167, G01N 33/574, A61P 9/00, C12Q 1/68, A61K 31/277, A61K 31/18
US Classification:
514521, 514622, 514617, 514604, 514619, 435 611, 435 723, 435 71, 435 612, 435 792, 436501
Abstract:
Methods of treating Wnt/Frizzled-related diseases, comprising administering niclosamide compounds are provided. Methods of predicting whether a disease will respond to treatment with a niclosamide compound are also provided.